140 related articles for article (PubMed ID: 20626878)
1. Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer.
Shen CX; Wen Z; Qian YH; Mu SF; Guan XF
J Exp Clin Cancer Res; 2010 Jul; 29(1):94. PubMed ID: 20626878
[TBL] [Abstract][Full Text] [Related]
2. [Enhanced thymidine kinase gene vector and its killing effect on nasopharyngeal carcinoma in vitro and in vivo].
Shen CX; Wen Z; Qian YH; Guan XF; Mu SF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 May; 45(5):414-9. PubMed ID: 20654181
[TBL] [Abstract][Full Text] [Related]
3. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
4. [Tumor-targeted human telomerase reverse transcriptase promoter/tk gene therapy against human nasopharyngeal carcinoma cells in vitro].
Xu F; Wen Z; Qiu YZ; Xiao JY; Zhao SP; Guo MH
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):695-9. PubMed ID: 20423828
[TBL] [Abstract][Full Text] [Related]
5. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
6. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
7. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
[TBL] [Abstract][Full Text] [Related]
8. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
[TBL] [Abstract][Full Text] [Related]
9. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
10. Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancer.
Tong X; Engehausen DG; Freund CT; Agoulnik I; Oehler MK; Kim TE; Hasenburg A; Guo Z; Contant CF; Woo SL; Kieback DG
Hybridoma; 1999 Feb; 18(1):93-7. PubMed ID: 10211795
[TBL] [Abstract][Full Text] [Related]
11. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
12. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
14. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S
Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of lentivirus-mediated hTERTp-TK combined with hTERTp-tumstatin on human hepatocarcinoma HepG2 cells].
Meng YX; Niu X; Deng ZH
Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):837-43. PubMed ID: 26743244
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
17. [Anti-nasopharyngeal carcinoma effect in vivo and in vitro of Avastin and adenovirus-thymidine kinase suicide gene].
Sha D; He YJ; Wang WB; Han JQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jul; 42(7):526-32. PubMed ID: 17886683
[TBL] [Abstract][Full Text] [Related]
18. [Study on the relationship between TK gene regulated by enhanced suicide gene vector and telomerase activity in nasopharyngeal carcinoma cells].
Shen C; Wen Z; Qian Y; Mu S; Guan X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Feb; 24(4):168-73. PubMed ID: 20422982
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo.
Akyürek LM; Nallamshetty S; Aoki K; San H; Yang ZY; Nabel GJ; Nabel EG
Mol Ther; 2001 May; 3(5 Pt 1):779-86. PubMed ID: 11356082
[TBL] [Abstract][Full Text] [Related]
20. The effect of HSV-tk/GCV on hepatic specific damage driven by murine ALB promoter/enhancer.
Zhang Y; Huang SZ; Zeng YT
Yi Chuan Xue Bao; 2004 Oct; 31(10):1053-60. PubMed ID: 15552038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
